stocks logo

ATNF

180 Life Sciences Corp
$
3.000
+0.87(40.845%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
3.4094
Open
2.800
VWAP
2.87
Vol
16.55M
Mkt Cap
1.43M
Low
2.325
Amount
47.52M
EV/EBITDA(TTM)
--
Total Shares
941.59K
EV
1.72M
EV/OCF(TTM)
--
P/S(TTM)
--
180 Life Sciences Corp. is a biotechnology company, which focuses on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis. Its programs include Anti-TNF (Clinical), Synthetic Cannabinoid Analogs (SCAs), and a7nAChR (Preclinical). The Company also operates a back-end technology platform to operate an online blockchain casino.
Show More

Valuation Metrics

The current forward P/E ratio for 180 Life Sciences Corp (ATNF.O) is -0.01, compared to its 5-year average forward P/E of -18.85. For a more detailed relative valuation and DCF analysis to assess 180 Life Sciences Corp 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-18.85
Current PE
-0.01
Overvalued PE
43.47
Undervalued PE
-81.18

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
3.37
Current PS
0.36
Overvalued PS
14.38
Undervalued PS
-7.63

Financials

Annual
Quarterly
FY2025Q1
YoY :
+13.41%
-2.37M
Operating Profit
FY2025Q1
YoY :
+121.48%
-2.37M
Net Income after Tax
FY2025Q1
YoY :
-60.12%
-0.67
EPS - Diluted
FY2025Q1
N/A
Free Cash Flow
FY2025Q1
N/A
ROIC

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

ATNF News & Events

Events Timeline

2025-07-01 (ET)
2025-07-01
07:49:36
180 Life Sciences announces grants of two patents
select
2025-05-01 (ET)
2025-05-01
09:37:55
180 Life Sciences announces notice of allowance for U.S. patent
select
2025-04-30 (ET)
2025-04-30
08:55:21
180 Life Sciences to repurchase 1.32M shares from Elray for $1M
select
Sign Up For More Events

News

2.0
07-21Benzinga
Why Block Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
9.5
07-18Benzinga
Why Interactive Brokers Group Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
9.5
05-23Benzinga
Why Intuit Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Sign Up For More News

FAQ

arrow icon

What is 180 Life Sciences Corp (ATNF) stock price today?

The current price of ATNF is 3 USD — it has increased 40.85 % in the last trading day.

arrow icon

What is 180 Life Sciences Corp (ATNF)'s business?

arrow icon

What is the price predicton of ATNF Stock?

arrow icon

What is 180 Life Sciences Corp (ATNF)'s revenue for the last quarter?

arrow icon

What is 180 Life Sciences Corp (ATNF)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for 180 Life Sciences Corp (ATNF)'s fundamentals?

arrow icon

How many employees does 180 Life Sciences Corp (ATNF). have?

arrow icon

What is 180 Life Sciences Corp (ATNF) market cap?